Literature DB >> 25217237

Antibiotic treatment of constipation-predominant irritable bowel syndrome: the puzzle is yet to be solved.

Sanjeev Sachdeva1, Raghuram Kondala, Amol Sonyabapu Dahale, Amarender Singh Puri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25217237     DOI： 10.1007/s10620-014-3352-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  10 in total

Review 1.  Methane on breath testing is associated with constipation: a systematic review and meta-analysis.

Authors:  David Kunkel; Robert J Basseri; Marc D Makhani; Kelly Chong; Christopher Chang; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2011-02-01       Impact factor: 3.199

2.  Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity.

Authors:  Mark Pimentel; Henry C Lin; Pedram Enayati; Brian van den Burg; Hyo-Rang Lee; Jin H Chen; Sandy Park; Yuthana Kong; Jeffrey Conklin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-11-17       Impact factor: 4.052

3.  Rifaximin therapy for patients with irritable bowel syndrome without constipation.

Authors:  Mark Pimentel; Anthony Lembo; William D Chey; Salam Zakko; Yehuda Ringel; Jing Yu; Shadreck M Mareya; Audrey L Shaw; Enoch Bortey; William P Forbes
Journal:  N Engl J Med       Date:  2011-01-06       Impact factor: 91.245

4.  Neomycin improves constipation-predominant irritable bowel syndrome in a fashion that is dependent on the presence of methane gas: subanalysis of a double-blind randomized controlled study.

Authors:  Mark Pimentel; Soumya Chatterjee; Evelyn J Chow; Sandy Park; Yuthana Kong
Journal:  Dig Dis Sci       Date:  2006-07-11       Impact factor: 3.199

5.  Low-dose nocturnal tegaserod or erythromycin delays symptom recurrence after treatment of irritable bowel syndrome based on presumed bacterial overgrowth.

Authors:  Mark Pimentel; Walter Morales; Sheila Lezcano; Dai Sun-Chuan; Kimberly Low; Janet Yang
Journal:  Gastroenterol Hepatol (N Y)       Date:  2009-06

6.  A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test.

Authors:  Kimberly Low; Laura Hwang; Johnson Hua; Amy Zhu; Walter Morales; Mark Pimentel
Journal:  J Clin Gastroenterol       Date:  2010-09       Impact factor: 3.062

7.  Antibiotic treatment of constipation-predominant irritable bowel syndrome.

Authors:  Mark Pimentel; Christopher Chang; Kathleen Shari Chua; James Mirocha; John DiBaise; Satish Rao; Meridythe Amichai
Journal:  Dig Dis Sci       Date:  2014-05-01       Impact factor: 3.199

8.  Methanogenic flora is associated with altered colonic transit but not stool characteristics in constipation without IBS.

Authors:  Ashok Attaluri; Michelle Jackson; Jessica Valestin; Satish S C Rao
Journal:  Am J Gastroenterol       Date:  2009-12-01       Impact factor: 10.864

9.  The degree of breath methane production in IBS correlates with the severity of constipation.

Authors:  Soumya Chatterjee; Sandy Park; Kimberly Low; Yuthana Kong; Mark Pimentel
Journal:  Am J Gastroenterol       Date:  2007-04       Impact factor: 10.864

10.  Breath methane positivity is more common and higher in patients with objectively proven delayed transit constipation.

Authors:  Kang-Moon Lee; Chang-Nyol Paik; Woo Chul Chung; Jin-Mo Yang; Myung-Gyu Choi
Journal:  Eur J Gastroenterol Hepatol       Date:  2013-06       Impact factor: 2.566
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.